DNA cytometry testing for cervical cancer screening - Response

Clinical Cancer Research

Volumn 16, Issue 13, 2010, Pages 3517-3519

  Tong, Hua ^a   Shen, Rong ^a   Kan, YanJing ^a   Wang, ZhuMing ^a   Wang, YiQuan ^b   Li, FengShan ^a   Wang, FuZhou ^a,c   Yang, Jie ^c   Guo, XiRong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; COLPOSCOPY; CYTOLOGY; CYTOMETRY; EARLY DIAGNOSIS; LETTER; PLOIDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; WART VIRUS;

EID: 77954239074     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1081     Document Type: Letter

References (5)

1. Tong H, Shen R, Wang Z, et al, Mass Cervical Cancer Screening Regimen Group. DNA ploidy cytometry testing for cervical cancer screening in China (DNACIC Trial): a prospective randomized, controlled trial. Clin Cancer Res 2009;15:6438-45.
2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006;56:11-25. (Pubitemid 43228384)
3. Lorenzato M, Caudroy S, Nou JM, et al. Contribution of DNA ploidy image cytometry to the management of ASC cervical lesions. Cancer 2008;114:263-9.
4. Bollmann R, Bankfalvi A, Griefingholt H, et al. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany. Oncol Rep 2005;13:915-22.
5. Lorenzato M, Clavel C, Masure M, et al. DNA image cytometry and human papillomavirus (HPV) detection help to select smears at high risk of high-grade cervical lesions. J Pathol 2001;194:171-6.